Clinical Trials on Small Bowel Polyp in Colombia
Total 864 results
-
Synta Pharmaceuticals Corp.CompletedCrohn's DiseaseUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
ShireCompletedCrohn's DiseaseKorea, Republic of, United States, Spain, France, Serbia, Netherlands, Germany, Japan, Austria, Belgium, Poland, Canada, Norway, Slovakia, South Africa
-
National Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer | Squamous Lung DysplasiaUnited States, Canada
-
University of British ColumbiaProvidence Health & Services; International Spinal Research Trust; International...RecruitingSexual Dysfunction, Physiological | Spinal Cord Injuries | Neurogenic Bowel | Neurogenic Bladder | Spinal Cord StimulationCanada
-
NCIC Clinical Trials GroupCompleted
-
BiogenTerminatedCrohn's DiseaseUnited States, Puerto Rico
-
Hoffmann-La RocheActive, not recruitingCrohn DiseaseUnited States, Belgium, Hungary, France, Poland, Canada, Bulgaria, Spain, Germany, Slovakia
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NRF2 Gene Mutation | NFE2L2 Gene MutationUnited States
-
AbbVieIronwood Pharmaceuticals, Inc.Enrolling by invitationIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Canada, Israel, Netherlands
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell LungArgentina, Colombia, Uruguay, Chile
-
ShireCompletedShort Bowel SyndromeUnited States, Canada, Finland, Belgium, Italy, United Kingdom, Germany
-
Ironwood Pharmaceuticals, Inc.CompletedIrritable Bowel Syndrome With ConstipationUnited States, Canada
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.RecruitingTriple Negative Breast Cancer | Non-small Cell Lung Cancer | Hormone Receptor Positive Breast CancerUnited States, Japan
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Alimentiv Inc.Academic Medical Organization of Southwestern OntarioActive, not recruitingCrohn Disease | RemissionCanada, United Kingdom, Ukraine, Italy
-
Prometheus LaboratoriesNestlé Health Science Spain; Nestec Ltd.Terminated
-
Millennium Pharmaceuticals, Inc.CompletedCrohn's DiseaseUnited States, Canada
-
Ontario Clinical Oncology Group (OCOG)Canadian Cancer Society (CCS)CompletedNon-small Cell Lung CancerCanada
-
ShireCompletedShort Bowel SyndromeUnited States, France, Germany, Canada, Netherlands, Poland, Denmark, Belgium, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non Small Cell Lung CancerUnited States, Australia, France, Italy, South Africa, Spain, United Kingdom, Sweden, Philippines, Germany, Hong Kong, Argentina, Israel, Portugal, Greece, Taiwan, Mexico, Belgium, Venezuela, Colombia, India
-
Bausch Health Americas, Inc.CompletedIrritable Bowel Syndrome Characterized by ConstipationUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingExtensive Stage Lung Small Cell CarcinomaUnited States
-
AbbVieNot yet recruitingUlcerative Colitis (UC)United States, Puerto Rico
-
Genzyme, a Sanofi CompanyTerminatedCrohn DiseaseSwitzerland, United States, New Zealand, Canada, Australia, Brazil, United Kingdom, Ukraine, Russian Federation, Argentina
-
TakedaActive, not recruitingCrohn's DiseaseUnited States
-
Peregrine PharmaceuticalsCompletedNon-small-cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
AbbVieTerminated
-
ShireCompletedCrohn's DiseaseKorea, Republic of, United States, Spain, Japan, Serbia, Germany, Belgium, Netherlands, Poland, Austria, Bulgaria, Canada, France, Norway, Slovakia, South Africa
-
PfizerCompletedCrohn's DiseaseKorea, Republic of, Canada, United States, Spain, Netherlands, Australia, Israel, Croatia, Japan, Germany, Hungary, Bulgaria, Austria, Czech Republic, France, Greece, South Africa, Ukraine
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
ArdelyxCompletedConstipation Predominant Irritable Bowel SyndromeUnited States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Inflabloc PharmaceuticalsCompletedAn Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's DiseaseCrohn's DiseaseUnited States, Canada
-
Menarini GroupTerminatedIrritable Bowel Syndrome With DiarrheaGermany, Sweden, United States, United Kingdom, Hungary, Poland, Latvia, Slovakia, Czech Republic
-
PfizerAthersys, IncCompletedColitis, UlcerativeUnited States, Canada, Germany, Italy, Hungary, Belgium, Slovakia, Sweden
-
CelgeneCompletedCrohn DiseaseUnited States, Australia, Canada, Slovakia, Hungary
-
Janssen Research & Development, LLCCompletedColitis, UlcerativeFrance, Ukraine, United States, Poland, Bulgaria, Canada, Netherlands, Belgium, Russian Federation, Germany, Hungary, Czech Republic
-
AbbottCompletedCrohn's DiseaseUnited States, Australia, Belgium, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, South Africa, Spain, Sweden, United Kingdom
-
Tioga PharmaceuticalsRTI Health SolutionsCompletedDiarrhea Predominant Irritable Bowel SyndromeUnited States
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerUnited States, Spain, China, France, Canada, Italy
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico